RxDoctor Payments Data

Laurell Conder, NP

Family · Gideon, MONPI 1255992897

Payments from drug & device makers

$1,850in general payments, 2019–2025

Across 102 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$572
  • GSK$566
  • Amgen$279
  • Pfizer$93
  • Lilly USA, LLC$67
  • Novo Nordisk$55
  • plus $217 from 7 others

What the payments were for

  • Food & beverage$1,850100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,850 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$8,156
Medicare patients
51
Services billed
1,817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter139$91,015
Breztri AerosphereBudesonide/Glycopyr/Formoterol115$83,964
FarxigaDapagliflozin Propanediol113$75,867
NuplazidPimavanserin Tartrate12$59,185
RybelsusSemaglutide46$56,000
OzempicSemaglutide54$52,896
MounjaroTirzepatide34$42,981
EliquisApixaban45$35,215
Repatha SureclickEvolocumab60$33,627
EntrestoSacubitril/Valsartan36$31,353
TrulicityDulaglutide28$27,418
JardianceEmpagliflozin25$26,026
UbrelvyUbrogepant17$24,518
JanuviaSitagliptin Phosphate36$21,084
XareltoRivaroxaban27$19,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga, Brilinta$572$167,356245 claims
Novo NordiskRybelsus, Ozempic$55$108,896100 claims
GSKTrelegy Ellipta, Anoro Ellipta$566$96,706151 claims
Lilly USA, LLCMounjaro, Trulicity$67$70,40062 claims
AbbVieUbrelvy, Linzess$37$35,46938 claims
PfizerEliquis$93$35,21545 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.

Other family in Gideon

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →